These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39031819)

  • 1. The diagnostic yield of genetic and metabolic investigations in syndromic and nonsyndromic patients with autism spectrum disorder, global developmental delay, or intellectual disability from a dedicated neurodevelopmental disorders genetics clinic.
    Postma JK; Harrison MA; Kutcher S; Webster RJ; Cloutier M; Bourque DK; Yu AC; Carter MT
    Am J Med Genet A; 2024 Nov; 194(11):e63791. PubMed ID: 39031819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
    Srivastava S; Love-Nichols JA; Dies KA; Ledbetter DH; Martin CL; Chung WK; Firth HV; Frazier T; Hansen RL; Prock L; Brunner H; Hoang N; Scherer SW; Sahin M; Miller DT;
    Genet Med; 2019 Nov; 21(11):2413-2421. PubMed ID: 31182824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).
    Carter MT; Srour M; Au PB; Buhas D; Dyack S; Eaton A; Inbar-Feigenberg M; Howley H; Kawamura A; Lewis SME; McCready E; Nelson TN; Vallance H;
    J Med Genet; 2023 Jun; 60(6):523-532. PubMed ID: 36822643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.
    Lee JS; Hwang H; Kim SY; Kim KJ; Choi JS; Woo MJ; Choi YM; Jun JK; Lim BC; Chae JH
    Ann Lab Med; 2018 Sep; 38(5):473-480. PubMed ID: 29797819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Twede H; Vanzo R; Harward E; Hensel CH; Martin MM; Page S; Peiffer A; Mowery-Rushton P; Serrano M; Wassman ER
    Biomed Res Int; 2016; 2016():3284534. PubMed ID: 27975050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of on-site clinical genetics consultations on diagnostic rate in children and young adults with autism spectrum disorder.
    Munnich A; Demily C; Frugère L; Duwime C; Malan V; Barcia G; Vidal C; Throo E; Besmond C; Hubert L; Roland-Manuel G; Malen JP; Ferreri M; Hanein S; Thalabard JC; Boddaert N; Assouline M
    Mol Autism; 2019; 10():33. PubMed ID: 31406558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genetic analysis of children with unexplained neurodevelopmental delay and neurodevelopmental comorbidities in a Chinese cohort using trio-based whole-exome sequencing.
    Wu R; Li X; Meng Z; Li P; He Z; Liang L
    Orphanet J Rare Dis; 2024 May; 19(1):205. PubMed ID: 38764027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
    Shin S; Yu N; Choi JR; Jeong S; Lee KA
    Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic yield of the chromosomal microarray analysis in turkish patients with unexplained development delay/ıntellectual disability(ID), autism spectrum disorders and/or multiple congenital anomalies and new clinical findings.
    Akkus N; Cubuk PO
    Mol Biol Rep; 2024 Apr; 51(1):577. PubMed ID: 38664339
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Roston A; Evans D; Gill H; McKinnon M; Isidor B; Cogné B; Mwenifumbo J; van Karnebeek C; An J; Jones SJM; Farrer M; Demos M; Connolly M; Gibson WT; ;
    J Med Genet; 2021 Mar; 58(3):196-204. PubMed ID: 32546566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating Neurogenetics for Child and Adolescent Psychiatry Practice.
    Hauptman AJ; Salpekar JA; Cohen JS; Asato MR
    J Am Acad Child Adolesc Psychiatry; 2024 Jul; 63(7):666-669. PubMed ID: 38325519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test.
    Arteche-López A; Gómez Rodríguez MJ; Sánchez Calvin MT; Quesada-Espinosa JF; Lezana Rosales JM; Palma Milla C; Gómez-Manjón I; Hidalgo Mayoral I; Pérez de la Fuente R; Díaz de Bustamante A; Darnaude MT; Gil-Fournier B; Ramiro León S; Ramos Gómez P; Sierra Tomillo O; Juárez Rufián A; Arranz Cano MI; Villares Alonso R; Morales-Pérez P; Segura-Tudela A; Camacho A; Nuñez N; Simón R; Moreno-García M; Alvarez-Mora MI
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
    Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
    Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Counseling in Neurodevelopmental Disorders.
    Blesson A; Cohen JS
    Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31501260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus heterogeneity in two siblings presenting with developmental delay, intellectual disability and autism spectrum disorder.
    Brugger M; Brunet T; Wagner M; Orec LE; Schwaibold EMC; Boy N
    Gene; 2021 Feb; 768():145260. PubMed ID: 33164824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Yield of Chromosomal Microarray Analysis in a Cohort of Patients with Autism Spectrum Disorders from a Highly Consanguineous Population.
    Al-Mamari W; Al-Saegh A; Al-Kindy A; Bruwer Z; Al-Murshedi F; Al-Thihli K
    J Autism Dev Disord; 2015 Aug; 45(8):2323-8. PubMed ID: 25703031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.